US EditionPublished • loading... • Updated
Cholesterol Transporter ABCA1 Boosts Macrophage-Driven Cancer Immunity
Higher ABCA1 levels in myeloid cells correlate with increased cancer-killing T cells and improved breast cancer outcomes, supporting new immunotherapy strategies.
Summary by News Medical
2 Articles
2 Articles
Cholesterol transporter ABCA1 boosts macrophage-driven cancer immunity
In recent years, cancer researchers have made major breakthroughs by using the body's immune system to fight cancer. One of the most promising approaches, known as immune checkpoint blockade, works by releasing molecular "brakes" on T cells.
·United States
Read Full Article
ABCA1 protein releases molecular brakes on solid tumor immunotherapy, study finds
In recent years, cancer researchers have made major breakthroughs by using the body's immune system to fight cancer. One of the most promising approaches, known as immune checkpoint blockade, works by releasing molecular "brakes" on T cells. This allows them to better recognize and attack cancer cells. While these therapies can be very effective for some patients, many solid tumors, including most forms of breast cancer, remain largely unaffecte…
Coverage Details
Total News Sources2
Leaning Left0Leaning Right0Center2Last UpdatedBias Distribution100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium
